Banner Health has appointed Dr. John Rares Almasan as senior vice president, chief AI, data and infrastructure officer, signaling a broader push by large integrated delivery systems to modernize the data backbone that increasingly underpins nutrition-related clinical research and outcomes tracking. While the role is squarely an enterprise technology appointment, its downstream implications for functional food and nutraceutical stakeholders are worth watching.
Large health systems like Banner — which operates dozens of hospitals and outpatient facilities — generate substantial real-world evidence on dietary supplement use, functional ingredient interactions, and nutrition-linked clinical endpoints. As AI-driven infrastructure matures within these networks, the potential to accelerate peer-reviewed, double-blind, placebo-controlled nutrition studies using de-identified patient data grows considerably. Ingredient suppliers and finished formulation brands have increasingly sought partnerships with health systems to generate the kind of robust clinical data that supports structure-function claims and, in some cases, disease-risk-reduction claims under FDA guidelines.
The functional foods and nutraceuticals sector has faced persistent pressure to close the evidence gap between promising in-vitro findings and human clinical endpoints. Health system AI platforms capable of mining longitudinal patient records could help researchers identify relevant cohorts faster, reduce recruitment timelines, and improve statistical power in studies examining bioavailability, standardized extract dosing, or CFU viability in probiotic interventions. For brands navigating the NDI (New Dietary Ingredient) notification process or building dossiers for GRAS self-affirmation, access to real-world outcomes data is a meaningful competitive asset.
The broader digital health and AI-in-healthcare market has attracted significant investment, with health system technology modernization projects increasingly intersecting with the $50-plus billion global dietary supplement industry's demand for credentialed clinical evidence. Co-manufacturing and white-label partners that supply to hospital retail, outpatient pharmacy, and wellness clinic channels may find that AI-forward health systems become more discerning — and more data-driven — procurement partners over the coming years.
Dr. Almasan's appointment has not been accompanied by specific disclosures about vendor relationships or research partnership priorities. Functional News will monitor whether Banner's infrastructure modernization creates new pathways for nutrition science collaboration, particularly as the clinical nutrition and personalized health segments seek institutional credibility for next-generation ingredient platforms.
Written by Michael Politz, Author of Guide to Restaurant Success: The Proven Process for Starting Any Restaurant Business From Scratch to Success (ISBN: 978-1-119-66896-1), Founder of Food & Beverage Magazine, the leading online magazine and resource in the industry. Designer of the Bluetooth logo and recognized in Entrepreneur Magazine's "Top 40 Under 40" for founding American Wholesale Floral, Politz is also the Co-founder of the Proof Awards and the CPG Awards and a partner in numerous consumer brands across the food and beverage sector.